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PENUBUHAN KULTUR HALUS DAN AMPAIAN SEL 
Artemisia annua L. BERASAL DARI VIETNAM 
 
ABSTRAK 
Kultur halus daripada tiga klon Artemisia annua L. diinduksikan daripada eksplan 
daun plantlet aksenik.  Medium asas MS dan LV ditambah dengan 0.5 mg/L BA, 0.5 
mg/L NAA dan 0.5 g/L kasein hidrolisat telah digunakan sebagai medium induksi. 
Tiga klon A. annua, iaitu klon TC1, TC2 dan Highland menunjukkan perbezaan 
dalam pertumbuhan dan rupa halus. Medium asas MS didapati adalah medium 
induksi kultur halus yang lebih baik berbanding dengan medium asas LV. Secara 
umum pertumbuhan kultur halus adalah lebih baik dari segi hasil biojisim dan 
kerapuhan apabila diinduksikan dalam medium asas MS berbanding  dengan medium 
asas LV. Keupayaan induksi kalus ketiga-tiga klon ini dalam medium MS yang 
ditambahkan dengan pikloram (0-2.0 mg/L) adalah berbeza.  Klon Highland A. 
annua dipilih untuk digunakan dalam kajian seterusnya kerana kalus dapat 
diinduksikan dengan baik secara konsisten dalam medium MS yang ditambahkan 
dengan 0.5 mg/L BA, 0.5 mg/L NAA dan 0.5 g/L kasein hidrolisat, dan MS yang 
ditambahkan dengan 0.5 mg/L pikloram. Walau bagaimanapun, apabila kultur halus 
klon Highland A. annua disubkultur, medium MS yang ditambahkan dengan 2.0 
mg/L pikloram didapati lebih sesuai sebagai medium proliferasi. Seterusnya kultur 
ampaian sel klon Highland A. annua ditubuhkan dalam medium cecair MS yang 
ditambahkan dengan  2.0 mg/L pikloram. Corak pertumbuhan sel A. annua 
menunjukkan bahawa  pertumbuhan maksimum sel dicapai 18 hari selepas dikultur. 
Pertumbuhan sel dapat ditingkatkan dalam medium MS dengan kekuatan berganda 
sama ada dalam pencahayaan atau kegelapan. Fotokala 16 jam cahaya dapat 
merangsang pertumbuhan sel yang lebih tinggi berbanding fotokala lain. Elisitasi 
xiii 
 
dengan arginin (4, 6, 10 mg/L) juga boleh meningkatkan pertumbuhan sel. Manakala 
elisitasi dengan kasein hidrolisat (0-1.0 g/L) dan ekstrak yis (0-2.0 g/L) tidak 
menunjukkan perbezaan dari segi pertumbuhan sel pada hari-hari elisitasi yang 
berlainan. Elisitasi dengan 2.0 g/L ekstrak yis satu hari selepas inokulasi sel tidak 
diteruskan kerana berlaku kematian sel. Kesan elisitasi gabungan kasein hidrolisat 
(0-1.0 g/L) dan ekstrak yis (0-1.0 g/L) juga dikaji dalam keadaan pencahayaan dan 
kegelapan. Respon sel terhadap elisitasi gabungan adalah berbeza dalam 
pencahayaan dan kegelapan. Ini menunjukkan terdapat interaksi antara pencahayaan 
dan kesan elisitasi gabungan. Artemisinin tidak dapat dikesan dalam kultur halus and 
ampaian sel A. annua tetapi sesquiterpene dan sebatian lain yang tidak dikenali  
mungkin wujud. Sebatian-sebatian ini mungkin adalah sebatian perantara dalam 
biosintesis artemisinin. 
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ESTABLISHMENT OF CALLUS AND CELL 
SUSPENSION CULTURE OF Artemisia annua L. OF 
VIETNAMESE ORIGIN 
 
ABSTRACT 
Callus cultures from three clones of Artemisia annua L. were induced from the leaf 
explants of axenic plantlets.  MS and LV basal media supplemented with 0.5 mg/L 
BA, 0.5 mg/L NAA and 0.5 g/L casein hydrolysate were used as induction medium. 
The three clones of A. annua, namely TC1, TC2 and Highland clones, showed 
difference in callus growth and appearance. MS basal medium was found to be the 
better callus induction medium as compared to LV basal medium. Generally callus 
growth was better in terms of biomass yield and friability when induced on MS basal 
medium than it was on LV medium. Callus induction capacity of the three clones 
using MS medium supplemented with picloram (0-2.0 mg/L) was different.  A. 
annua Highland clone was selected for further study as the callus  could be induced 
consistently well in MS medium supplemented with 0.5 mg/L BA, 0.5 mg/L NAA 
and 0.5 g/L casein hydrolysate, and MS supplemented with 0.5 mg/L picloram. 
However, when callus of A. annua Highland clone was subcultured, MS medium 
supplemented with 2.0 mg/L picloram was found to be suitable as proliferation 
medium. Subsequently cell suspension culture of A. annua Highland clone was 
established in liquid MS medium supplemented with 2.0 mg/L picloram. Growth 
pattern of A. annua indicated that maximum cell growth was achieved 18 days after 
culture. Cell growth could be enhanced in double strength MS medium either under 
illumination or darkness. Photoperiod of 16-hour light was able to stimulate higher 
cell growth as compared to that of other photoperiods. Elicitation with arginine (4, 6, 
10 mg/L) also improved cell growth. While elicitation with casein hydrolysate (0-1.0 
xv 
 
g/L) and yeast extract (0-2.0 g/L) did not show any distinct cell growth on different 
feeding days. Elicitation with 2.0 g/L yeast extract one day after cell inoculation was 
discontinued as cell death occurred. Effect of combined elicitation of casein 
hydrolysate (0-1.0 g/L) and yeast extract (0-1.0 g/L) was also studied under light 
illumination and darkness. Cells response to combined elicitation was distinct under 
light illumination and under darkness. This indicated that there was interaction 
between light illumination and combined elicitation effect. Artemisinin was not 
detected in the callus and cell cultures of A. annua but sesquiterpene and other 
unidentified compounds were probably present. This could possibly be intermediate 
compounds related to artemisinin biosynthesis. 
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CHAPTER ONE 
INTRODUCTION 
Artemisia annua L. (Family: Asteraceae, formerly Compositae),  is an annual 
herbaceous plant native to Asia, most probably China (McVaugh, 1984). It is 
endemic to steppe vegetation in Chahar and Suiyuan  provinces (40° N and 109° E) 
in northern China and distributed between 1000 to 1500 m above sea level (Wang, 
1961). The generic name Artemisia refers to Artemis (Greek name for Diana), 
goddess of maternity, for since antiquity, plants from this genus has been used to 
regulate menstrual disorders, to control pangs of childbirth and as an abortifacient. 
Many ancient herbalists such as Theophrastus in the third century B.C., Pliny and 
Dioscorides in the first century, and Gerard in 1597, had recorded the existence of 
Artemisia species as reviewed by Riddle and Estes (1992).  
Aerial parts of A. annua were prescribed as treatment for fevers in the 
Chinese Handbook of Prescriptions for Emergency Treatments in A.D. 340. In 1527, 
huang hua hao (identified as Artemisia annua) was used by Li Shi-Zhen, a Chinese 
herbalist to treat children‟s fever (Klayman, 1993). A. annua is an annual plant while 
most other species of this genus are either biennial or perennial.  At least 40 volatiles 
can be found as constituents of the essential oil from Artemisia annua, making this 
species an interesting source of essential oil (Simon et al., 1990, Charles et al., 1991) 
However, its great significance in medicinal and thus economic interests is mainly 
due to it being probably the only species of Artemisia genus able to synthesize 
artemisinin (Baraldi et al., 2008).  
 Artemisinin, a sesquiterpene lactone endoperoxide, is considered the most 
important secondary metabolite and bioactive constituent of A. annua ( Heppner and 
Ballou, 1998, Van Agtmael et al., 1999). This compound has been discovered in 
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leaves, small green stems, buds, flowers, seeds (Acton et al., 1985, Zhao and Zeng, 
1985, Liersch et al., 1986, Singh et al., 1986, Martinez and Staba, 1988, 
Madhusudanan, 1989, Ferreira and Janick, 1995b), but could not be detected in roots 
of field-grown plants or pollen ( Pras et al., 1991, Ferreira and Janick, 1995a). The 
greatest amount of artemisinin was found in the inflorescence. At anthesis, 
artemisinin content was more than 10 times the artemisinin found in leaves (Ferreira 
and Janick, 1995a). However other reports indicated otherwise. Baraldi et al. (2008) 
reported significantly higher artemisinin content in leaves than in inflorescences at 
full bloom. Liu et al. (2007) found that upper leaves of A. annua contained more 
artemisinin than in flower buds. Interestingly, leaves from different height of the 
plant gave varying amount of artemisinin ( Delabays et al., 2001, Liu et al., 2007). 
Artemisinin has also been isolated from in vitro-grown plants (Nair et al., 1986, 
Whipkey et al., 1992, Ferreira and Janick, 1995b).  
Artemisinin has been traditionally used to treat fevers, and haemorrhoids, in 
aromatic wreaths and currently as potent antimalarial drug (Ferreira et al., 1997). 
Artemisinin, along with its derivatives is a proven treatment for a number of diseases 
besides malaria including hepatitis B and parasites that cause schistosomiasis 
(Dhingra et al., 2000, Borrmann et al., 2001, Utzinger et al., 2001). Artemisinin has 
been reported to be effective against a variety of cancer cell lines including breast 
cancer, human leukemia, colon, and small-cell lung carcinoma (Efferth et al., 2001, 
Singh and Lai, 2001) as well as drug-resistant cancers (Efferth et al., 2002, Sadava et 
al., 2002). Furthermore, it is relatively a safe drug with no obvious adverse reactions 
or side effects, even for pregnant women (WHO, 2003). 
Malaria, one of the most devastating diseases in the tropical world, has been 
recorded in as far back as the sixteenth century B.C. in Egypt. In the fifth century, 
3 
 
followers of Hippocrates observed a connection of the disease to marshes (Klayman, 
1985). In 1989, Ronald Ross, an English physician working in India, and Giovanni 
Battista Grassi, an Italian physician, has independently proven that the disease was 
spread by the bite of the female Anopheles mosquito (Cox, 2002). Malaria is a 
serious endemic disease in many part of the world, affecting 5% of the world 
population. About 40% of the world population is at stake of malaria. Four major 
Plasmodium species, namely P. falciparum, P. vivax, P. malariae and P. ovale are 
known to cause human malaria. P. falciparum being the most prevailing parasite 
species across the globe which causes cerebral malaria that is often fatal to children 
(Wirth et al., 1986). Epidemiological data estimated that there were 221 million P. 
falciparum attacks in Africa in 1995 (Snow et al., 1999).  In 2002 the estimate was 
365 million clinical cases in Africa (Snow et al., 2005), followed by 119 million 
cases estimated in South East Asia. P. falciparum were mainly focused in the African 
region (70%), but the highly populated South East Asia region contributed 25% of 
the world‟s clinical attacks in 2002. Approximation of world population at risk was 
2,211 million and 515 million clinical cases.  
Fighting malaria is ridden with technical, logistic and economical problems. 
Malaria poses a major setback to the economy of developing tropical countries and 
successful control of this disease is important for improved world health (Wirth et 
al., 1986). Chloroquine has been the mainstay of antimalarial drug treatment for the 
past 40 years, but resistance is now widespread (Bloland et al., 1993). Resistance to 
pyrimethamine-sulphadoxine (PSD) as a successor to chloroquine developed as well 
(White et al., 1999). And similar scenario occurred with the use of mefloquine in 
southeast asia (Van Vugt et al., 1998)  . The World Health Organization (WHO) has 
endorsed artemisinin-based combination therapy (ACT) as the “policy standard” for 
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treating malaria infections caused by P. falciparum (RBM, 2004, Davis et al., 
2005a). Artemisinin increases efficacy and has the prospective of slowing the speed 
of emerging and spread of resistance (Mutabingwa, 2005).  International efforts have 
been made through programmes such as the Global Burden of Diseases to enumerate 
malaria-related health consequences (Murray and Lopez, 1997, WHO, 1999), the 
Roll Back Malaria initiative to cut the burden of malaria within six years (WHO, 
1999) and the Millennium Development Goal‟s target to put a stop to increasing 
malaria cases by 2015 (UNDP, 2003), clearly reflect the magnitude of the malaria 
plague and the urgency to address the prevalence of this disease. Increasing severity 
of this disease and death rate resulting from it is compounded by continuous 
infestation and spread of resistance to antimalarial drugs among Plasmodium 
parasites. Even though immunity to malaria is acquired after several years of 
recurring infections, it remains partially effective. An effective vaccine is the best 
long term control option for malaria. But till date, vaccine development remains at 
pre-clinical stage (Dhingra et al., 2000). As effective antimalarial vaccine is not 
available and occurrence of drug-resistant parasites is increasing, the need to develop 
novel antimalarial drugs to curb the spread of this disease becomes more urgent. 
At present, artemisinin forms the basis of a large family of drugs 
recommended by World Health Organization (WHO) to fight against malaria. 
Artesunate, the main derivative of artemisinin, has been suggested to be employed as 
prescription for severe illness of pregnant women and children in low transmission 
area (Dondrop and Day, 2007). However, low and inconsistent yield of artemisinin, 
0.01 – 0.08% (Simon et al., 1990, Abdin et al., 2003,) from field cultivation 
depending on plant materials , genotype, and seasonal and geographic variations   
hamper efforts to produce sufficient artemisinin to meet the annual global demand of 
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20 – 22 t yr -1 (Charles et al., 1991, van Geldre et al., 1997, Bhakuni et al., 2001, 
WHO, 2005, Vaz et al., 2006).  
 Ravindranathan (1990) has described various methods of chemical synthesis 
of artemisinin. However, such de novo synthesis is complicated, uneconomical and 
provides low yield of artemisinin suggesting that plant source might be a valid 
alternative (Dhingra et al., 2000). Artemisinin yield from field cultivation in India 
was reported by Singh et al. (1986) to be 3.7 kg/ha for Washington strains of A. 
annua. Such yield from field is far too low as compared to 15 kg of artemisinin per 
ha yield for commercial purpose. Assuming that in future, the maximum artemisinin 
yield  per ha is 20 kg, enough for 15,000 to 20,000 applications (Woerdenbag et al., 
1990), and to estimation that 500 million people are treated against malaria yearly 
(Snow et al., 2005), an area of 25,000 ha (250 km
2
) of A. annua plantation could be 
sufficient to provide the necessary amount of artemisinin to treat these patients.  
Therefore the enhanced production of artemisinin via biotechnological 
techniques has been considered as a viable approach. In vitro propagation of 
Artemisia annua using shoot cultures has been reported (Nair et al., 1986, Martinez 
and Staba, 1988, Elhag et al., 1992, Woerdenbag et al., 1993). Callus culture was 
established in medium supplemented with auxin and cytokinins combinations 
(Martinez and Staba, 1988, Ferreira and Janick, 1996, Rao and Narasu, 1998). Cell 
suspension culture had also been established from callus culture (Woerdenbag et al., 
1993, Chan and Nallammai, 2001, Nallammai and Chan, 2002, Baldi and Dixit, 
2007). However, presence of artemisinin in callus and cell cultures has been 
contradictory, (Woerdenbag et al., 1991, Elhag et al., 1992, Woerdenbag et al., 1993, 
Paniego and Giulietti, 1994). 
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Considering the importance of artemisinin which is tedious and difficult to 
synthesize chemically, it is important to identify the best clone of A. annua with high 
artemisinin content. Therefore the present study was conducted to serve the 
following aims: 
a) to identify the suitable medium for callus induction and callus growth for three 
clones of Artemisia annua, of Vietnam origin, namely TC1, TC2 and Highland 
b) to select one clone of Artemisia annua for cell suspension study based on growth 
and friability of callus of the three different clones  
c) to study the effect of physical and chemical factors on the growth of cells in the 
cell suspension culture 
d) to optimise the cell culture condition for improved cell growth and artemisinin 
yield by combining both the physical and chemical factors 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 2 
LITERATURE REVIEW 
2.1 Artemisia annua 
2.1.1  Artemisia species  
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Artemisia annua belongs to the Artemisia genus which consists of about 400 
species worldwide (Heywood and Humphries, 1977). Artemisia genus is part of the 
Astereacea, a big family consists of more than 1,600 genera and 23,000 species. This 
family is the second largest family of flowering plants in terms of number of species. 
It includes ornamental plants that produce beautiful asters, garden perennials of 
which many have medicinal values and fragrance. This family has been widely 
known and placed in the order Asterales (Ferreira et al., 1997). 
The genus Artemisia comes under the the Anthemideae tribe of the 
Asteroideae, a subfamily of the Asteraceae. Artemisia is a fairly large genus with 100 
to 200 known species and many are commonly known as some form of sagebrush or 
wormwood such as silver sagebrush (Artemisia cana Prush), birdfoot sagebrush 
(Artemisia pedatifida Nutt.) and Alaska wormwood (Artemisia alaskana 
Rydb.)(Greger et al., 1986). 
 Species of Artemisia are usually shrubs, with divided leaves and 
inconspicuous flower. A. annua is a large shrub, usually single-stemmed with 
alternate branches. growing more than 2 m height. Its aromatic leaves are deeply 
dissected, ranging from 2.5 to 5 cm in length. The chromosome number is 2n = 18 
(Bennett et al., 1982).  
 
 
 
2.1.2 Floral Biology 
A. annua is a determinate short-day plant. Non-juvenile plants are very 
responsive to photoperiodic stimulus and flowering occurs two weeks after 
induction. Non-juvenile plants in greenhouse studies, flowered after being subjected 
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to 8-, 10-, or 12-hour photoperiods for two weeks, but remained vegetative under  
16-, 20-, 24-hour photoperiods.  In field studies conducted in northern temperate 
zone, the first flower buds were produced when day length was 12:57 hour. 
Greenhouse data further implied that flowering occurred two weeks earlier when day 
length was 13:31 hour (Ferreira and Janick, 1995a).  
The greenish-yellow nodding flowers (capitula) are 2 to 3 cm in diameter, 
with calyses composed of numerous, imbricated bracts. These capitula contain 
numerous bisexual florets in the centre and pistillate marginal florets with stigma 
extrusion. Both flowers have synpetalus tubular corolla with the top split into 5 lobes 
in the hermaphroditic florets and into 2 to 3 lobes in the pistillate florets. The bifid 
stigma, also known as pollen presenter has modified acuminate epidermal cell that 
assist in pollen capture. Active pollen presenter in Asteraceae is characterized by 
growing style pushing  the pollen presenter past the anthers. Pollens from the anthers 
are then collected  and extruded  for presentation and dispersion by wind. The five 
stamens have bilocular anthers, attached to the bottom of the corolla, inferior to the 
top of the style. Each stamen has a lanceolate appendix at the top, which alternates 
with the lobes of the corolla (Ferreira and Janick, 1995a). Ovaries are inferior and 
unilocular, each generating one achene, 1 mm in length and slightly nerved. Typical 
in anemophylous species, the pollen is tricolpate and relatively smooth with internal 
collumellae-tecta complex configuration in the exine. The pollen is extremely 
allergenic, as in other Artemisia species  due to the presence of allergenic proteins on 
the exine surface (Park et al., 1993).  
Insects and wind action help to cross-pollinate this plant. This method is 
rather unusual in the Asteraceae (McVaugh, 1984). Based on light and scanning 
electron microscopy examination on floral morphology, the capitula was thought to 
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be adapted for self-pollination (Ferreira and Janick, 1995a) but experimental data 
showed that self-pollination is rare and difficult to achieve, inferring the presence of 
self-incompatibility in A. annua, a common feature among members of Asteraceae 
family (North, 1979).  
 
2.1.3  Glandular Trichomes 
The presence of trichomes and glands containing volatile monoterpenes and 
sesquiterpenes are common in the Asteraceae family (Mehrotra et al., 1990). Duke 
and Paul (1993) found biseriate glandular trichomes in the leaves of A. annua at the 
earliest stage of development but later become obscured by filamentous T-trichomes. 
These two types of trichomes are arranged in two rows along either side of the leaf 
midrib. On the abaxial surface of leaf and stems, these trichomes are arranged 
randomly.  Glandular trichomes are also found on florets of A. paniculata, A. 
Mauiensis and a range of other species. Kelsey and Shafizadeh (1980) reported 
biseriate glandular trichomes on both leaf surfaces of A. nova. This type of trichome 
is found on floral stalks of A. tridentata (Slone and Kelsey, 1985), on both leaf 
surfaces and ovary surface of A. umbelliformis (Cappelletti et al., 1986) and in the 
adaxial surface of A. campestris (Ascensao and Pais, 1987).  
Duke and Paul (1993) has provided very detail description on the origin of 
biseriate glands in leaves by using light, scanning and transmission microscope. The 
earliest stage of gland formation observed is the 1-cell stage, in which the single 
epidermal cell enlarges and protrudes above the leaf surface. This cell expands and 
divides anticlinally and again, periclinally into four cells. Throughout these stages, 
vacuoles are relatively small and only few unstacked thylakoids are found in 
proplastids. At 6-cell stage, chloroplasts are present with stacked thylakoids with 
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absence of starch grains. Lack of starch grains is the only distinguishing feature 
between chloroplasts of glands and mesophyll tissues. Further periclinal division of 
the two apical cell layers results in the final 10-cell stage. After all 10 cells are 
formed, the cuticular surface of the gland begins to separate from the cell wall, near 
the tip of the gland. The onset of cuticular detachment is believed to be due to onset 
of secretory activity. Subcuticular space borders the six apical cells of the gland. 
Cytoplasm is denser at this stage than earlier, and the two basal cells contain 
chloroplasts and relatively large vacuoles. The apical cell pairs have no chloroplasts 
and the subapical 2-cell pairs contain large, amorphous chloroplasts without starch 
grains. 
Ten-celled biseriate glandular trichomes are abundant in the bracts, 
receptacles and florets of the capitulum in A. annua. These glands which can be 
found on both both pistillate and hermaphroditic florets from earliest developmental 
stages are easily ruptured, releasing volatile oils when the florets are pressed. The 
floral biseriate trichomes are formed in the same way as leaf glandular trichomes.  
Due to absence of artemisinin and artemisitene in glandless biotype of A. 
annua, Duke et al. (1994) concluded that the subcuticular spaces of the biseriate 
glandular trichomes in leaves are the sites of sequestration of these compounds. 
Extraction of artemisinin and artemisitene can be done from 5-second leaf dip in 
chloroform, without visible damage to other leaf epidermal cells. Artemisinin can 
also be extracted by a 1-minute dip of inflorescences in petroleum ether or 
acetonitrile (Ferreira and Janick, 1995a) 
 
2.2  Chemical constituents of Artemisia annua 
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Extensive search for new antimalarial drugs which began in 1967, following 
developing resistance of Plasmodium falciparum to chloroquine in 1960s, led to 
isolation of an active malarial fraction from Artemisia annua in 1971. The 
biologically active compound was isolated and named artemisinin in 1972 and the 
structure was elucidated in 1979. Screening of artemisinin in other Artemisia species 
(Rucker et al., 1986, Klayman et al., 1984, O'neill et al., 1985, Liersch et al., 1986, 
Balachandran et al., 1987) revealed that only Artemisia apiacea contains artemisinin 
other than A. annua (Liersch et al., 1986). 
Besides artemisinin, other related sesquiterpene lactones are arteannuic acid 
(Tu et al., 1982), 6,7-dehydroarteannuic acid (El-Feraly et al., 1989), arteannuin B 
(Tu et al., 1982, Jeremic et al., 1973), arteannuin C (Misra, 1986), and epi-
deoxyartemisinin B (Roth and Acton, 1987, El-Feraly et al., 1989), artemisitene 
(Acton and Klayman, 1985) and deoxyartemisinin (Xu et al., 1986). The presence of  
guaianolides and seco-guaianolides were also reported by Huneck et al. (1986).  
The essential oil in this plant is mainly found in its leaves and has limited 
perfumery and pharmaceutical value (Lawrence, 1982). Composition of this essential 
oil includes sesquiterpenes and mainly monoterpenes. The primary component is 
artemisia ketone, whose structure deviates from classic isoprene (Allen et al., 1977). 
Other monoterpenes which are found abundantly in the essential oil are borneol, 1,8-
cineole, α-pinene, thymol, carvacrol and camphor. Among the sesquiterpenes, 
caryophyllene and caryophyllene oxides are the most important (Banthorpe et al., 
1983, Lawrence, 1982, Risinger et al., 1978). There was also report on the presence 
of α-myrcene and β-myrcene hydroperoxides (Rucker et al., 1987). Furthermore, A. 
annua  contains flavonoids (Baraldi et al., 2008, Bhardwaj et al., 1985, Jeremic et 
al., 1973, Misra, 1986, Shilin et al., 1989), long chain hydrocarbons (Ulubelen and 
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Halfon, 1976), acetylens (Bohlmann and Zdero, 1972) and coumarins (Anon., 1982a, 
Shilin et al., 1989).  
 
2.2.1  Chemical Properties of Artemisinin 
Artemisinin is a rare sesquiterpene lactone endoperoxide, which can be 
extracted from A. annua. This novel compound  was isolated for the first time in 
1972 (Anon., 1979, Anon., 1982b) and its structure was later established using 
combined spectral, chemical and X-ray analysis (Zhongshan et al., 1985, Liu et al., 
1979, Blasko et al., 1988, Leban et al., 1988). Sesquiterpene lactones are known for 
wide varieties of biological activities such as cytotoxic and antitumour activities. 
These group of compound also show antibiotic properties, act as phytotoxins, 
mammalian toxins, insect-feeding deterrents as well as causing allergic contact 
dermatitis (Rodriguez et al., 1976, Picman, 1986).  
Zeng et al. (1983) reported that artemisinin is sensitive to acid and base 
treatment, yet stable when heated in neutral solvents at 150 °C for 2.5 min. Klayman 
et al. (1984) found out that 20% artemisinin is destroyed when it is subjected to 48-
hr boiling in ethanol, whereas similar boiling treatment in isopropanol did not lead to 
compound decomposition. Lin et al. (1985) revealed that no artemisinin can be 
detected after heating at 190 °C for 10 min, even though the molecule is not affected 
at 200 °C heating temperature, above its 156-157 °C-melting point. Cleavage of 
peroxide bridge results in thermal decomposition, forming free radical intermediates, 
which either rearrange or decompose. In another study on thermal decomposition of 
artemisinin, Luo et al. (1985) refluxed artemisinin in xylene for 22 hours, causing 
breakage of 30% of the peroxide group. It is also light stable (Anon., 1982b) 
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Its empirical formula is C15H22O5. It is colourless and odourless. It forms 
crystals with melting point of 156 - 157°C. Its molecular weight is m/e 282.1742 m+ 
as determined by high resolution mass spectroscopy (Luo and Shen, 1987). 
 
2.2.2 Artemisinin Content in the Plant 
Artemisinin is sequestered in the glandular trichome on the biseriate leaves 
and inflorescenses (Duke et al., 1994, Ferreira et al., 1997). Glandular trichomes can 
be found in early stage of flower formation, but artemisinin content was maximum at 
full blooming stage (anthesis).  
The content of artemisin was higher in leaves than in inflorescences when 
flowers approach full bloom (Baraldi et al., 2008). The presence of 
polymethoxyflavonoids in the phytocomplex enhances the bioavailability of 
artemisinin (Elford et al., 1987). Castisin, a flavonoids discovered in A. annua, was 
found to inhibit some cytophysiological activities of Plasmodium falciparum (Yang 
et al., 1995)  
Highest level of artemisinin from cultivated plants is 0.01 to 1.4% dry weight, 
(van Agtmael et al., 1999). Artemisinin yield is usually low and varies according to 
different plant parts, growing conditions, and seasonal and geographic variations 
(Abdin et al., 2003). Variation in artemisinin concentration can be attributed to 
different stages in vegetative growth and diverse plant parts between strain origin 
(Laughlin et al., 2002). There were inconsistent reports on the developmental stage at 
which artemisinin content is the highest: just before flowering (ElSohly et al., 1990, 
Acton and Klayman, 1985, Woerdenbag et al., 1991) or at the point of full flowering 
(Pras et al., 1991, Ferreira and Janick, 1995, Morales et al., 1993). Later in the 
season, due to loss of leaves, lower part of the plant contains only little artemisinin 
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(Acton and Klayman, 1985, Liersch et al., 1986, Singh et al., 1986).  ElSohly et al. 
(1987) and Roth and Acton (1987) reported an overall drop in artemisinin content 
when leaves disappeared as flowers developed. 
Baraldi et al. (2008) reported artemisinin content of 0.04 to 0.05% of plant 
dried weight from Italian variety. Artemisinin content from plants of other European 
origin was reported to be 0.03 to 0.22% (Trigg, 1990, Charles et al., 1991,). 
Concentrations in plants of China origin vary in the range of 0.01 – 0.5 % based on 
dry weight (Klayman, 1985). A variety, probably Asia origin, grown in the USA 
contained 0.06% artemisinin in dried leaves and flowers but plant stems were devoid 
of this compound (Klayman et al., 1984).  
Artemisinin and its precursors were not found in the roots (Abdin et al., 
2003). Ferreira et al. (1995) reported artemisinin content in flowers  was 4 – 5 times 
than in leaves. Artemisinin content also differ with plant development, indicating a 
possible correlation between plant age and artemisinin yield.  
 
2.2.3  Biosynthesis of Artemisinin 
The complete biosynthetic pathway of artemisinin and some of its precursors 
has yet to be fully understood. Comprehensive biosynthetic knowledge for 
artemisinin production is critical in increasing the compound yield by 
biotechnological means (Dhingra et al., 2000).  
Artemisinin belongs to the sesquiterpenes group, whose precursor is farnesyl 
diphosphate, FDP (C15). FDP is synthesized from mevalonic acid diphosphate via 
isopentenyl  diphospahate (IPP) and geranyl diphosphate (Akhila et al., 1987). There 
are two independent pathways leading to IPP formation: mevalonate pathway 
(MVA) stemming from acetyl CoA, and the mevalonate independent pathway (MEP) 
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originating from pyruvate. IPP and its isomer, dimethylallyl  diphosphate (DMAPP) 
then lead to other terpenoids. Prokaryotes and eukaryotes use different pathway for 
IPP production but plants use both pathwyas (Croteau et al., 2000). MVA pathway in 
plants occurs in the cytosol, while MEP pathway is localised in plastids. According 
to Adam and Zapp (1998) and Laule et al. (2003), there is evidence for possible 
exchange of IPP between these two pathways. In MEP pathway, IPP is derived from 
condensation of pyruvate with D-glyceraldehyde-3-phosphate. Deoxy-D-xylulose-5-
phosphate synthase (DXS) catalyses the condensation of pyruvate and D-
glyceraldehyde-3-phosphate to 1-deoxy-D-xylulose-5-phosphate. In the following 
step, 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR) converts 1-deoxy-D-
xylulose-5-phosphate to 2-C-methyl-D-erythritol-4-phosphate (Mahmoud and 
Croteau, 2001, Souret et al., 2002, Souret et al., 2003). In the MVA pathway, 
mevalonic acid is produced from the reduction of 3-hydroxy-3-methylglutaryl 
(HMG)-Co-A by 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) (Mahmoud 
and Croteau, 2001, Souret et al., 2002, Souret et al., 2003).  
 Post-FDP production pathway is not yet completely elucidated. However it is 
clear that the first critical step in the artemisinin biosynthesis is the cyclization of 
FDP to amorpha-4,11-diene  by amorphadiene synthase (ADS) (Bouwmeester et al., 
1999). Cytochrome 450 enzyme was believed to be responsible for the conversion of 
amorpha-4,11-diene  to artemisinic alcohol. Further oxidation by either cytochrome 
450 enzyme or dehydrogenase produces artemisinic acid. The double bond between 
C11 and C13 of artemisinic acid is thought to be reduced to dihydroartemisinic acid. 
Dihydroartemisinic acid is then further modified to artemisinin non-enzymatically 
(Abdin et al., 2003, Wallaart et al., 1999) 
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2.2.4 Antimalarial Activities of Artemisinin and its Derivatives 
Artemisinin has proven to be effective in clinical trials in 1980s and semi-
synthetic derivatives has been developed to improve the pharmalogical and 
antimalarial properties (Hien and White, 1993, Klayman, 1985). The unique 1,2,4-
trioxane structure of artemisinin is entirely incompatible with the traditional anti-
malarial structure-activity theory (Wu, 2002). It was suggested that the mode of 
action of these types of agents is altogether different from those of the traditional 
alkaloidal antimalarial agents (Anon, 1982a).  The actions of artemisinin derivatives 
is different from that of the other antimalarial drugs, although both the artemisinin 
drugs and the 4-aminoquilines interact with haem (Meshnick et al., 1989, Meshnick 
et al., 1993). Most of the antimalarials show bioactivity at the late trophozoite and 
schizont stage, but artemisinin derivatives act at early trophozoite and ring stages. 
Ring stage refers to presence immature trophozoites in the erythrocytes following the 
invasion of schizont released from ruptured liver cells. Therefore artemisinin only 
affects blood-stage parasites, not liver-stage parasites or stages within mosquito, 
making their action stage specific (Kamchonwongpaisan and Meshnick, 1996). They 
are also gametocytocidal (Dutta et al., 1990, Mehra and Bhasin, 1993).  
Studies in monkeys have proven that artemisinin is effective in impairing life 
cycle and thus transmission of Plasmodium cynomolgi B (simian malaria) within 18 
to 24 hours even in single intramuscular doses (Dutta et al., 1989). Pharmacological 
studies and clinical observations in every type of malaria infection showed that 
artemisinin had direct parasiticidal action on Plasmodium in the erythrocytic stage 
but is ineffective in the exoerythrocytic, liver stage (Ferreira et al., 1997).   
Artemisinin derivatives are highly effective against sexual and asexual forms of 
human-infectious Plasmodium species due to their most rapid initial reduction in 
17 
 
parasitaemia as compared to other antimalarial drugs (Hien and White, 1993, de 
Vries and Dien, 1996, Chen et al., 1998). The endoperoxide moiety in artemisinin 
structure was thought to cause destructive free-radical generation within the parasite 
and alters the roles of key parasite proteins (Meshnick, 1998, Eckstrein-Ludwig et 
al., 2003). This is in agreement with the observation that derivatives of artemisinin 
are devoid of antimalarial activity in the absence of peroxide moiety (Anon, 1982b). 
Several studies had shown support for oxygen-mediated toxicity. Drugs, such as 
miconazole and doxorubicin, were assumed to exert their effect by increasing oxygen 
stress, thus enhancing artesunate activity. Contrary, artemisinin activity was reduced 
by catalase, dithiothreitol and α-tocopherol (Krungkai and Yuthavong, 1987). 
Reactive oxygen intermediates were produced by artemisinin and artesunate at 
increased pH (Acton and Klayman, 1987, Meshnick et al., 1989). Ascorbic acid and 
reduced glutathione, acting as antioxidants, were found to inhibit antimalarial 
activity of artemisinin in vitro  (Meshnick et al., 1989). In vitro studies had indicated 
that the carbonyl function was not necessary for antimalarial activity (Jung et al., 
1990). 
The action of artemisinin and its derivatives was not antagonised by p-
aminobbenzoic acid, indicating that they were different from that of both chloroquine 
and antifolate drugs (Sinha et al., 1987). Chinese researchers had proposed that the 
membrane system of the parasite was the main site of artemisinin action (Anon, 
1982a). Ultrastructural changes of the erythrocytic  stage parasites  appeared within 1 
to 4 hours after exposure to artemisinin in vivo (Ye et al., 1983). Ellis et al. (1985) 
found morphological changes in the ribosomes and the endoplasmic reticulum, along 
with accumulation of tritium-labelled dihydroartemisinin in the membranes. Jiang et 
al. (1985) observed mitochondrial swelling within Plasmodium innui parasite in 
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infected monkeys, but not within the host cells after exposure to artemisinin. Such 
changes lead to the formation of autophagic vacuoles and loss of cytoplasm, which 
kills the parasites (Anon., 1979, Maeno et al., 1993). Browning and Brisby (1989) 
stated that antimalarial action of artemisinin was not due to direct effect on the lipid 
structure of the parasite membrane. Gu et al. (1986) reported haemolysis of red blood 
cells when exposed to artemisinin concentration exceeding those necessary for 
antimalarial activity. Gu et al. (1986) also showed that protein synthesis in 
erythrocytes infected with P. falciparum was inhibited by artemisinin, 
dihydroartemisinin and artemether. Inhibition of nucleic acid synthesis occurred later 
than protein synthesis inhibition (Li et al., 1983), and hence suggested that nucleic 
acid was not the primary target of drug action (Gu et al., 1983). Artemisinin also 
affects polyamine metabolism. This was shown by Zhao et al. (1986) who studied 
cytochrome oxidase activity on Plasmodium bergheri. In another study by Gu et al. 
(1984), accumulation of tritiated dihydroartemisinin in P. falciparum-infected 
erythrocytes was significantly higher than that in uninfected erythrocytes, indicating 
a selective uptake of the drug by infected cells. Efficacy of sodium artesunate was 
exhibited by its inhibition on activity of cytochrome oxidase (Zhao et al., 1986), and 
glutamine transport system (Elford, 1986) in erythrocytes.  
No parasite-resistance cases were reported with the use of artemisinin 
derivatives (White, 2004). Severity of infection did not significantly affect the 
pharmacokinetics of artemisinin derivatives (Davis et al., 2001) and dose adjustment 
was not necessary for patients with hepatic or renal impairment. Important drug 
interactions are not known (Ilett and Batty, 2004). High recrudescence rate, usually 
more than 25% after short courses of artemisinin between 3 and 5 days highlights the 
limitations of monotherapy. 
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Sodium artelinate is the most active compound in the water-soluble 
artemisinin derivatives series. Although it is less potent than sodium artesunate, it 
compares favourably with this drug both in vitro against P. falciparum and in vivo 
against P. berghei. Sodium artelinate is also more stable than artesunate. Sodium 
artesunate hydrolyses in alkaline solution in a few hours, while sodium artelinate 
undergoes little decomposition after three months (Lin et al., 1987). Arteether, 
artemether, sodium artesunate, artelinic acid and sodium artelinate are more stable 
and effective against malaria than artemisinin and dihydroartemisinin. However the 
latter compounds were less cytotoxic when tested in vitro (Woerdenbag et al., 
1993b). In whole animal systems, dihydroartemisinin is the most potent and most 
toxic compound. Although artemisinin is the least effective, it is also the easiest 
compound to manufacture. 
 
2.2.5  Artemisinin-based Combination Therapies 
The rationale for combining drugs with independent modes of action to 
prevent emergence of resistance was first developed in antituberculosis 
chemotherapy. This approach has since been adopted for cancer chemotherapy and 
for the treatment of AIDS and early HIV-1 infection (White et al., 1999). While 
other antimalarials can reduce malarial parasite biomass by 100-fold to 1,000-fold, 
artemisinin and its derivatives (artesunate, artemether and dihydroartemisinin) can 
reduce parasite biomass by roughly 10,000-fold per two-day asexual life cycle 
(White, 1997). Combinations of artemisinin, or one of its derivatives, with more 
slowly eliminated drugs such as mefloquine or lumefantrine have proven to be highly 
effective, even against multidrug-resistant Plasmodium falciparum (Price et al., 
1997, van Vugt et al., 1998). The halt of progressive mefloquine resistance on north-
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western border of Thailand (White, 1997), which harbours the most resistant P. 
falciparum in the world with combination chemotherapy was attributed to two 
factors. First, high cure rates with combination chemotherapy eliminates most of the 
infection, leaving a residuum of only 10
5
 parasites or 0.000001 % of the initial 
asexual parasites exposed to mefloquine alone. As a result of rapid reduction of 
parasite population in a patient, the selective pressure for the emergence of mutants 
with reduced mefloquine sensitivity is lessened substantially (White, 1998). 
Secondly, significant decrease in gametocyte carriage prevents the spread of 
resistance. Price et al. (1996) and Handunnnetti et al. (1996) found that recrudescent 
infections were associated with the increase of gametocyte carriage rate, providing a 
powerful selection pressure to the spread of resistance. Thus, combinations should 
slow the evolution of drug resistance in all malarious areas (White et al., 1999).  
Combination chemotherapy does protect the artemisinin derivatives from 
development of resistance, as opposed to argument that artemisinin derivatives 
should be withheld from the use of uncomplicated malaria in order to prevent the 
development of resistance. Parasites were never exposed to the antimalarial activity 
of artemisinin derivatives alone if the drug was used with another unrelated 
antimalarial drug. Watkins and Msobo (1993) suggested that the resistance to this 
group of drugs would develop fairly slow. Furthermore, use of artemisinin has been 
poorly regulated in many countries, a condition that would provide selective pressure 
to the emergence of resistance. If these drugs were used only in combination with 
other antimalarials, artemisinin resistance would develop much more slowly. This 
mutual protection will give rise to a longer useful lifespan for both components in 
combined antimalarial chemotherapy than if the two components were used 
sequentially (van Vugt et al., 1998).  
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Artemisinin-based combination therapies  (ACT) combine rapid 
schizontocidal activity of artemisinin derivates with a longer half-life partner drug 
(Davis et al., 2001). Partner drugs in ACT should be well-tolerated with low toxicity, 
has broad spectrum of actions, able to clear asexual forms of Plasmodium rapidly 
and possess long half-life of more than four days. „Ideal‟ antimalarial combinations 
should have components with different modes of action, prescribed as short-course 
regimens (three days at most) and inexpensive (Nosten and Brasseur, 2002).  
Among the available derivatives, artesunate is the most favourable to be used 
in ACT treatment for uncomplicated malaria due to the presence of hemisuccinate 
group that confers water solubility and high oral bioavailability. Thus it can rapidly 
be converted to the potent active dihydroartemisinin (Davis et al., 2001). Artesunate-
mefloquine has been used widely in South-East Asia countries with 95% efficacy. 
However, neuropsychiatric effects of mefloquine are problematic (Hien et al., 2004). 
Artemether-lumefantrine, though recommended by WHO as the first line ACT 
combination has not been proven to be as effective as other types of ACT due to 
bioavailability and efficacy problems (Taylor and White, 2004, Omari et al., 2004) 
and  high treatment failure rate of 28% in 14 days (Poravuth et al., 2002). On the 
other hand, dihydroartemisinin-piperaquine is probably the most promising form of 
ACT (Davis et al., 2005a). Indochinese studies have shown cure rates above 95% in 
28 days (Denis et al., 2002, Hien et al., 2004) 
Before the development of ACT, combinations of chemotherapeutic agents 
such as quinine-tetracycline, sulfadoxine-pyrimethamine and atovaquone-proguanil, 
were used to improve cure rates and protect component drugs against resistance. 
However the application of these antimalarial combinations were hampered by 
frequent side-effects, long course regimens (quinine-tetracycline), increasing high-
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grade resistance (sulfadoxine-pyrimethamine) and high cost (atovaquone-proguanil) 
(Wichmann et al., 2004). 
The prospect of ACT is promising. Pyronaridine and naphthoquine, two 
novel partner drugs are being assessed and preliminary results are encouraging 
(WHO, 2001) and combination of artesunate with chlorproguanil-dapsone, two old 
antimalarial drugs is being developed (Alloueche et al., 2004). Van Vugt et al. 
(2002) found that combination of atovaquone-proguanil and artesunate was effective 
with multi-drug resistant Plasmodium falciparum. The future challenge in 
development of ACT is to build up a potent, safe, easy to administer and inexpensive 
range of antimalarial combinations (Davis et al., 2005b). 
 
2.3  Malaria 
2.3.1  History 
Malaria is one of the most important infectious diseases in the world, and its 
history extends into antiquity. It is generally believed that malaria arose with 
primates evolution in Africa and evolved with humans, spreading with human 
migrations throughout tropics, subtropics, and temperate regions of the Old World. 
Later the disease stretched on to the New World with explorers, missionaries and 
slaves. Klayman (1989) gathered some controversial suggestions of the possibility 
that malaria appearance in the pre-Columbian America was related to slaves 
importation from Africa.  
Malaria has been recorded since the sixteenth century B.C. in Egyptian 
writings. Symptoms reported includes shivering, fever and spleen enlargement. In the 
fifth century B.C., followers of Hippocrates noted the recurrence of fevers at regular 
intervals and found a connection of the disease to marshes. In the seventeenth 
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century, Italians thought that breathing bad air (mal aira) from the swamp was the 
cause of the disease. The term „malaria‟ became part of English medical literature in 
the first half of nineteenth century. The Spanish name for malaria (paludisme) and 
the Spanish name (paludismo) are in fact derived from palus in Latin, meaning 
marsh. These records indicate high malaria infection rates in/around swamp areas as 
stagnant water in these areas provides natural breeding ground for Anopheles 
mosquito, the vector of Plasmodium parasites that cause malaria (Klayman, 1985).  
The discovery of the malaria parasite and breakthrough in understanding its 
mode of transmission are among the most exciting events in the history of infectious 
disease. According to Cox (2002), the parasites in the blood were first observed in 
1880 by Alphonse Laveran, a French army surgeon. As cited by Cox (2002), Patrick 
Manson identified mosquito as the vector of malarial parasites in 1894 based on his 
knowledge that filarial worms, another blood parasites, were also transmitted by 
mosquitoes and because of the known association between malaria and mosquitoes 
breeding ground, the marshy places. Ronald Ross, an English physician and Battista 
Grassi, an Italian physician, independently proved that the bite of Anopheles female 
mosquito as the cause of malarial infection, thus solving the mystery of malaria 
transmission. Also cited by Cox (2002), Ross in 1897, found oocytes of P. 
falciparum  in an anopheline mosquito that fed on a patient  with gametocyte form of 
malaria parasite. Giovanni Battista Grassi, Amico Bignami and Giuseppe Bastianellli 
illustrated the developmental stages of malarial parasites in anopheline mosquitoes. 
As found in Cox (2002), the life cycle of of malarial parasites was only elucidated 
nearly 50 years later by Henry Shortt and Cyril Garnham in 1947, who showed that a 
phase of division in the liver preceded the development of parasites in the blood. 
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Prior to 1947, the 10-day whereabouts of the parasites development , which could not 
be seen in the blood, was not known.   
Life cycle of Plasmodium parasites is very complex, beginning with injected 
sporozoites into the blood of its host by the female anopheline mosquito. The 
sporozoites enter the liver and multiply, releasing thousands of daughter forms of 
merozoites into the blood. The merozoites invade red blood cells, where another 
phase of multiplication occurs. Some merozoites develop into male and female 
gametocytes, the sexual stages, to be taken up by female mosquitoes during feeding 
on humans. Fertilisation between these gametocytes occurs within the gut of the 
mosquitoes. Zygotes develops into oocysts, where another phase of multiplication 
occurs. As a result, sporoziotes are produced and upon reaching the salivary glands 
of the mosquito, are injected into a new host (Cox, 2002).  
 
2.3.2  Mortality and Morbidity 
In 1990, global incidence of malaria was estimated to be 213 million cases 
(Murray and Lopez, 1996). In 1998, an estimate of 273 million clinical cases or 
28.2% increase was reported, out of which 90% of global cases was borne by Africa 
(WHO, 1999). Snow et al. (2005) using a comprehensive standard global approach 
estimated a staggering 515 million clinical Plasmodium falciparum malaria episodes 
in 2002. At a regional level, 70% of clinical events came from African region and 
South East Asia contributed 25%. They produced a cartography of malaria risk, with 
figures up to 50% higher than those reported by World Health Organisation (WHO), 
claiming that WHO statistics has been understated due to its dependence on passive 
national notifications to WHO regional offices and Africa‟s weak system of reporting 
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infectious diseases. If such argument is valid, then the magnitude of global malarial 
prevalence is indeed much greater than that estimated by WHO. 
Death rate following a clinical attack of P. falciparum appears to be higher in 
Africa than in South-East Asia and western Pacific. Occurrence of life-threatening 
complications due to P. falciparum malaria in Africa (Snow, 1997) is at least ten-fold 
as compared to similar occurrence in India (Prusty and Das, 2001) and Vanuatu 
(Maitland, 1997). Reasons for such huge disparity were unclear but might include 
limited access to proper treatment (Alles et al., 1998) and cross-Plasmodium species 
defence against severe disease outcomes (Mayfong et al., 2004). 
Malaria has been wiped out from the United States and Cuba but remain 
prevalent largely in Africa. Large areas in Asia, Central and South America do 
record high incidences of this disease as well (Nussenzweig and Long, 1994). 
Travellers, migrant workers, military personnel and people living around 
international airports contribute to about 1000 cases reported annually in the United 
States (Wirth et al., 1986) 
 
2.3.3 Control of Malaria in Malaysia 
Malaria eradication Programme was started in Peninsular Malaysia in 1967 
and substituted with Malaria Control Programme in 1980 which was further extended 
to Sabah and Sarawak in 1986. In Peninsular Malaysia, malaria control was focused 
on three states where the borders of Kelantan, Pahang and Perak merged. Population 
in this area is largely aboriginal Orang Asli. Primary health-care approach to malaria 
control was introduced in 1995. In Sabah, Five-Year Action Plan for malaria control 
launched in 1996, yielded great success. In 1995, Sabah accounted for 84.2% of 
malaria burden in the country. By 2003, the state share of burden was reduced to 
